Cyclic GMP-phosphodiesterase of rd retina: biosynthesis and content.
Deficient cGMP-phosphodiesterase (cGMP-PDE) activity results in elevated levels of cGMP in the rd retina before any pathological signs are observed. Since the enzyme is present in rd retina, although it is barely activated by light, we determined whether its synthesis starts at the same time as that of cGMP-PDE in normal retina, or if either its synthesis is halted or degradation of the enzyme increases before the degeneration of the visual cells. We found that synthesis of cGMP-PDE in rd retina is comparable with that in normal retina while the photoreceptors are viable but that cGMP-PDE content is lower than that of normal retina before the visual cells begin to degenerate. Our results suggest that cGMP-PDE is more susceptible to degradation in rd than in normal photoreceptors or, alternatively, that proteolytic enzyme(s) involved in the degradation of cGMP-PDE are in higher concentration or more active in the defective than in the normal retina.
Farber
D B
DB
Department of Ophthalmology, UCLA School of Medicine, 90024-1771.
Park
S
S
Yamashita
C
C
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000096:biosynthesis / Q000378:metabolism*; D000818:Animals; D051379:Mice; D012160:Retina / Q000201:enzymology* / Q000254:growth & development; D012162:Retinal Degeneration / Q000201:enzymology*
D015106:3',5'-Cyclic-GMP Phosphodiesterases